Targeted pathogens include AIDS-causing HIV, hepatitis B and C, and the West Nile virus
The changes to kidney transplant rules are intended to make organ allocation more equitable.
Researchers identified a genetic glitch that promotes kidney scarring.
Living kidney donors who are in need of a transplant later in life experience shorter wait times and receive better quality kidneys.
Living kidney donors are more likely to be diagnosed with high blood pressure or preemclampsia once pregnant compared to non-donor.
An anticoagulant was found to preserve kidney function after transplantation.
Researchers may have found a predictor for focal segmental glomerulosclerosis (FSGS) in kidney transplant recipients.
More reimbursement and compensation opportunities should be available for living kidney donors.
This approach resulted in improved hypertension control in patients with autosomal dominant polycystic kidney disease, new study found.
The vast majority of kidney failure patients reported that they were doing fine on dialysis and did not see a need for a kidney transplant.
Researchers expect to start safety and performance testing of the Wearable Artificial Kidney (WAK) this autumn.
Ultrasound surveillance for renal tumors should be performed on native and graft kidneys from 3 years after transplantation.
Barriers to donation may explain why living donor kidney transplantation has been declining.
In adjusted analyses, female transplant recipients had a significantly increased risk of urologic cancer and men did not.
Graft survival was similar to that seen in concurrent single SCD kidney recipients
Improved renal function may contribute to the decline in a glycoprotein that inhibits bone formation.
Patients are more likely to receive a kidney transplant and less likely to die than patients with end-stage renal disease from other causes.
Black female hemodialysis patients less likely to want living transplant; more likely to receive offer.
For some highly sensitized patients, expanded criteria donor kidneys do not confer a survival edge over standard criteria donor kidneys.
Kidney transplanted from brain-dead donors or those who died from circulatory causes are associated with similar patient and graft survival.
Study compared single-dose alemtuzumab and multiple-dose rabbit anti-thymocyte globulin.
Using cephalexin instead of trimethoprim-sulfamethoxazole may decrease UTI incidence and cost of care.
Less than a high school education and delayed graft function are among the factors that increase the risk of readmission within 30 days.
A pre-transplant history of malignancy increases the 10-year post-transplant mortality risk by 22%.
Mean estimated glomerular filtration rate decreases by 0.57 mL/min/1.73 m2 annually with each 1-year increase in age at donation.
In a study, donors were 60% more likely to be diagnosed with gout than matched healthy controls.
They also are at elevated risk of cardiovascular and all-cause mortality, study finds.
No differences found in mortality, CVD between donors, nondonors older than 55.
At last follow-up, 41 of 43 patients who underwent partial nephrectomy did not require dialysis.
Delayed graft function is 41% more likely in obese than non-obese kidney transplant recipients.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)